Diabetes, cardiovascular risk and nephropathy.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Cardiology Clinics

• Publication date

  2010-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ccl.2010.04.006PMID 20621251
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Standards of Medical Care in Diabetes—2010

  2010cited by this paper
• Rosuvastatin and cardiovascular events in patients undergoing hemodialysis.

  2009cited by this paper
• Glucose control and vascular complications in veterans with type 2 diabetes.

  2009cited by this paper
• Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National

  2009cited by this paper
• Effects of Prandial Versus Fasting Glycemia on Cardiovascular Outcomes in Type 2 Diabetes: The HEART2D trial

  2009cited by this paper
• A randomized trial of therapies for type 2 diabetes and coronary artery disease.

  2009cited by this paper
• Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials

  2009cited by this paper
• Diabetes Patients Requiring Glucose-Lowering Therapy and Nondiabetics With a Prior Myocardial Infarction Carry the Same Cardiovascular Risk: A Population Study of 3.3 Million People

  2008cited by this paper
• Effect of a multifactorial intervention on mortality in type 2 diabetes.

  2008cited by this paper
• 10-year follow-up of intensive glucose control in type 2 diabetes.

  2008cited by this paper
• Standards of Medical Care in Diabetes—2008

  2008cited by this paper
• Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.

  2008cited by this paper
• Lifetime Risk of Cardiovascular Disease Among Individuals With and Without Diabetes Stratified by Obesity Status in the Framingham Heart Study

  2008cited by this paper
• Standards of Medical Care in Diabetes—2008 The recommendations in this article are based on the evidence reviewed in the following publication: Standards of care for diabetes (Technical Review). Diabetes Care 17:1514–1522, 1994. Originally approved 1988. Most recent review/revision, October 2007.

  2008cited by this paper
• Effects of intensive glucose lowering in type 2 diabetes.

  2008cited by this paper
• Diabetes and mortality following acute coronary syndromes.

  2007cited by this paper
• KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease.

  2007cited by this paper
• Mortality Trends in Men and Women with Diabetes, 1971 to 2000

  2007cited by this paper
• REVIEW: Efficacy and mechanisms of action of statins in the treatment of diabetic dyslipidemia.

  2006cited by this paper
• Management of dyslipidemias in patients with diabetes and chronic kidney disease.

  2006cited by this paper
• Prediction of Lifetime Risk for Cardiovascular Disease by Risk Factor Burden at 50 Years of Age

  2006cited by this paper
• Heart disease and stroke statistics--2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.

  2006cited by this paper
• Type 2 diabetes as a "coronary heart disease equivalent": an 18-year prospective population-based study in Finnish subjects.

  2005cited by this paper
• Should diabetes be considered a coronary heart disease risk equivalent?: results from 25 years of follow-up in the Renfrew and Paisley survey.

  2005cited by this paper
• Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.

  2005cited by this paper
• Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies

  2005cited by this paper
• The burden of mortality attributable to diabetes: realistic estimates for the year 2000.

  2005cited by this paper
• Glycemic control and coronary heart disease risk in persons with and without diabetes: the atherosclerosis risk in communities study.

  2005cited by this paper
• The relationship between dysglycaemia and cardiovascular and renal risk in diabetic and non-diabetic participants in the HOPE study: a prospective epidemiological analysis

  2005cited by this paper
• Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis.

  2005cited by this paper
• Intensive lipid lowering with atorvastatin in patients with stable coronary disease.

  2005cited by this paper
• Chronic Renal Dysfunction as an Independent Risk Factor for the Development of Cardiovascular Disease

  2005cited by this paper
• Effect of pravastatin in people with diabetes and chronic kidney disease.

  2005cited by this paper
• Postprandial glucose regulation and diabetic complications.

  2004cited by this paper
• Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial.

  2004cited by this paper
• Meta-Analysis: Glycosylated Hemoglobin and Cardiovascular Disease in Diabetes Mellitus

  2004cited by this paper
• Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.

  2004cited by this paper
• National cross sectional survey to determine whether the decision to delivery interval is critical in emergency caesarean section

  2004cited by this paper
• Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes.

  2003cited by this paper
• MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial.

  2003cited by this paper
• Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64).

  2003cited by this paper
• The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

  2003cited by this paper
• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.

  2002cited by this paper
• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Commentary

  2002cited by this paper
• Elevated risk of cardiovascular disease prior to clinical diagnosis of type 2 diabetes.

  2002cited by this paper
• Postchallenge hyperglycemia and mortality in a national sample of U.S. adults.

  2001cited by this paper
• Impact of diabetes on long-term survival after acute myocardial infarction: comparability of risk with prior myocardial infarction.

  2001cited by this paper
• The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years of follow-up.

  2001cited by this paper
• Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria.

  2001cited by this paper
• Risk Factors for Coronary Heart Disease in Diabetes

  2000cited by this paper
• Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group.

  2000cited by this paper
• The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus.

  2000cited by this paper
• Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.

  1998cited by this paper
• Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper
• Epidemiology of cardiovascular risk factors in chronic renal disease.

  1998cited by this paper
• Hyperlipidemia and diabetes mellitus.

  1998cited by this paper
• Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

  1998cited by this paper
• The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature.

  1997cited by this paper
• Banting lecture 1988

  1997cited by this paper
• The Impact of Diabetes on Survival Among Patients With First Myocardial Infarction

  1997cited by this paper
• Blood pressure and end-stage renal disease in men.

  1996cited by this paper
• Early predictors of 15-year end-stage renal disease in hypertensive patients.

  1995cited by this paper
• The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

  1993cited by this paper
• Role of Insulin Resistance in Human Disease

  1988cited by this paper
• Banting lecture 1988. Role of insulin resistance in human disease.

  1988cited by this paper
• Coronary heart disease in young Type 1 (insulin-dependent) diabetic patients with and without diabetic nephropathy: incidence and risk factors

  1987cited by this paper
• The effect of proteinuria on relative mortality in Type 1 (insulin-dependent) diabetes mellitus

  1985cited by this paper

• Association between life’s essential 8 and diabetic kidney disease: a population-based study

  2025cites this paper
• Lingering Effects of Hyperglycemia in Recently Diagnosed Diabetes During Long-term Follow-up of the DCCT/EDIC and UKPDS Cohorts: More Evidence That Early Control Matters

  2021cites this paper
• Diagnostic circulating biomarkers to detect vision‐threatening diabetic retinopathy: Potential screening tool of the future?

  2021cites this paper
• Association of high blood lead level and diabetic retinopathy among Saudi diabetic patients

  2020cites this paper
• Diabetic nephropathy in type 2 diabetes: The frequency and risk factors

  2019cites this paper
• Value of Estimated Glomerular Filtration Rate and Albuminuria in Predicting Cardiovascular Risk in Patients with Type 2 Diabetes without Cardiovascular Disease

  2018cites this paper
• Development and biological evaluation of vesicles containing bile salt of telmisartan for the treatment of diabetic nephropathy

  2018cites this paper
• High protein diet is of benefit for patients with type 2 diabetes

  2018cites this paper
• Hematopoietically expressed homeobox gene is associated with type 2 diabetes in KK Cg-Ay/J mice and a Taiwanese Han Chinese population

  2018cites this paper
• Autophagy and its link to type II diabetes mellitus

  2017cites this paper
• EVALUATING THE PRESCRIPTION OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS OR RECEPTOR BLOCKERS IN PATIENTS WITH DIABETES IN JORDAN.

  2017cites this paper
• Effects of high-dose parenteral vitamin D therapy on lipid profile and blood pressure in patients with diabetic nephropathy: A randomized double-blind clinical trial.

  2017cites this paper
• DIABETIC STUDIES The Review of Biomarkers in Diabetic Retinopathy

  2016cites this paper
• Biomarkers in Diabetic Retinopathy.

  2015cites this paper
• Adjusting for comorbidities in cost of illness studies

  2015cites this paper
• DIJABETIČKA NEFROPATIJA KAO UZROK KRONIČNE BUBREŽNE BOLESTI

  2015cites this paper
• Dyslipidemia in Nephrotic Syndrome

  2014cites this paper
• A prospective clinical trial of specialist renal nursing in the primary care setting to prevent progression of chronic kidney: a quality improvement report

  2014cites this paper
• Avaliação da função renal e sua associação com FVW, ADAMTS13 e dímero D em pacientes diabéticos tipo 1

  2014cites this paper
• Hypercoagulability and cardiovascular disease in diabetic nephropathy.

  2013cites this paper
• Effectiveness of a drug dosing service provided by community pharmacists in polymedicated elderly patients with renal impairment — a comparative study

  2013cites this paper
• The Old and New Methods of Assessing Kidney Function

  2012cites this paper
• Diabetes care among older adults in primary care in Austria--a cross-sectional study.

  2012cites this paper
• Telmisartan in the management of diabetic nephropathy: a contemporary view.

  2012cites this paper
• Percutaneous re-circulating isolated limb perfusion of gentamicin in a large animal model: targeted delivery of gentamicin to limb.

  2012cites this paper
• Reducing renal failure: how low do glucose levels need to go?

  2012cites this paper
• Risk factors for native kidney dysfunction in patients with abdominal multivisceral/small bowel transplantation

  2012cites this paper
• How to improve drug dosing for patients with renal impairment in primary care - a cluster-randomized controlled trial

  2012cites this paper
• Sodium-dependent glucose transporter protein as a potential therapeutic target for improving glycemic control in diabetes.

  2011cites this paper
• World Journal of Nephrology

  year unknowncites this paper